Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in ChinaYing Chi, Lunbiao Cui, Yiyue Ge et al.|The Journal of Infectious Diseases|2020Cited by 391
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19Yiyue Ge, Jianyang Zeng, Tingzhong Tian et al.|Signal Transduction and Targeted Therapy|2021Cited by 204
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19Yiyue Ge, Jianyang Zeng, Yipin Lei et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 168
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoVAleksandra Milewska, Krzysztof Pyrć, Ying Chi et al.|Journal of Virology|2020Cited by 102
Association of viral load with serum biomakers among COVID-19 casesFengjuan Shi, Bin Wu, Tao Wu et al.|Virology|2020Cited by 94